.Pharmacolibrary.Drugs.ATC.N.N02CD07 .Pharmacolibrary.Drugs.ATC.N.N02CD07| name: | Atogepant | |
| ATC code: | N02CD07 | route: | oral |
| compartments: | 1 | |
| dosage: | 60 | mg |
| volume of distribution: | 292 | L |
| clearance: | 19.7 | L/h |
| other parameters in model implementation | ||
Atogepant is an orally administered, small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist, used for the preventive treatment of migraine in adults. It is FDA-approved and is currently used in clinical practice for migraine prevention.
Pharmacokinetic parameters observed in healthy adult subjects after single and multiple oral doses.